Brachial arterial flow mediated dilation: Utility in clinical and experimental practice;Vasodilatación dependiente de endotelio en la arteria braquial: Uso en neurología clínica y experimental

Revista de Neurologia

Volumn 53, Issue 6, 2011, Pages 351-360

  Santos García, Diego ^a   Rodríguez Yáñez, Manuel ^a   Arias Rivas, Susana ^a   Blanco, Miguel ^a  

^a Hospital Clinico Universitario   (Spain)

Author keywords

Brachial artery; Endothelial dysfunction; Endothelium; Flow mediated dilation; Ischemic stroke

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CANDESARTAN; CARVEDILOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; METFORMIN; NEBIVOLOL; RAMIPRIL; SPIRONOLACTONE; ZOFENOPRIL;

ARTERY BLOOD FLOW; ARTERY DILATATION; ATHEROSCLEROSIS; BRACHIAL ARTERY FLOW MEDIATED DILATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; CORONARY RISK; ENDOTHELIUM; HIGH RISK PATIENT; HUMAN; MIGRAINE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; REVIEW; RISK REDUCTION; STROKE; SYNCOPE; THROMBOSIS; VALIDATION PROCESS;

EID: 80052977916     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5306.2011240     Document Type: Review

References (92)

1. Anderson TJ. Prognostic significance of brachial flow-mediated vasodilation. Circulation 2007; 115: 2373-5.
2. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986; 250: 1145-9.
3. Santos-Garcí D, Blanco M, Castillo J. The role of flow mediated dilation in ischemic stroke: time for action. European Neurological Journal 2010. URL: http://www.slm-neurology.com/uploads/media/The_Role_of_Flow-Mediated_Dilation_in_Ischemic_Stroke.pdf.
4. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-75.
5. Maseri A. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon. N Engl J Med 1997; 336: 1014-6.
6. Drexler H. Endothelial dysfunction: clinical implications. Prog Cardiovasc Dis 1997; 4: 287-324.
7. Libby P, Aikawa M, Jain MK. Vascular endothelium and atherosclerosis. Handb Exp Pharmacol 2006; 176: 285-306.
8. Blanco M, Rodríuez-Yáñez M, Sobrino T, Leira R, Castillo J. Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction. Cerebrovasc Dis 2005; 20 (Suppl 2): S32-9.
9. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51.
10. Celermajer DS, Sorensen KE, Gooch VM. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-5.
11. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-41.
12. Motoyama T, Kawano H, Kugiyama K, Okumura K, Ohgushi M, Yoshimura M, et al. Flow-mediated, endothelium-dependent dilatation of the brachial arteries is impaired in patients with coronary spastic angina. Am Heart J 1997; 133: 263-7.
13. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129: 111-8.
14. Schretzenmayer A. Uber Kreislaufregulatoische vörgönge and den grossen arterien bei der muskelarbeit. Pflugers Arch 1933; 232: S743-8.
15. Blanco-Gonzáez M, Santos-Garcí D, Castillo-Sáchez J. Ténicas ultrasonográicas en la valoració de la disfunció endotelial. Revista del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Españla de Neurolog? 2010; 8: 11-5.
16. Olesen SP, Clapham DE, Davies PF. Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature 1988; 331: 168-70.
17. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-9.
18. Ly Y, Zheng J, Bird IM, Magness RR. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells. Endothelium 2005; 12: 21-39.
19. Jin ZG, Wong C, Wu J, Berk BC. Flow shear stress stimulates Gab1 tyrosine phosphorylation to mediate protein kinase B and endothelial nitric-oxide synthase activation in endothelial cells. J Biol Chem 2005; 280: 12305-9.
20. Koller A, Sun D, Kaley G. Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993; 72: 1276-84.
21. Busse R, Edwards G, Féléou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci 2002; 23: 374-80.
22. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264: H150-6.
23. Martin CM, Beltrá-Del-Río A, Albrecht A, Lorenz RR, Joyner MJ. Local cholinergic mechanisms mediate nitric oxide-dependent flow-induced vasorelaxation in vitro. Am J Physiol 1996; 270: H442-6.
24. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 2001; 88: 145-51.
25. Agewall S, Hulthe J, Fagerberg B, Gottfridsson B, Wikstrand J. Post-occlusion brachial artery vasodilatation after ischaemic handgrip exercise is nitric oxide mediated. Clin Physiol Funct Imaging 2002; 22: 18-23.
26. Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ, et al. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) 2001; 101: 629-35.
27. Pyke KE, Tschakovsky ME. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 2005; 568: 357-69.
28. Kooijman M, Thijssen DH, De Groot PC, Bleeker MW, Van Kuppevelt HJ, Green DJ, et al. Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans. J Physiol 2008; 586: 1137-45.
29. Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am J Physiol 1995; 268: H1397-404.
30. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65.
31. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al; Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 7-17.
32. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al; Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23: 233-46.
33. Pyke KE, Dwyer EM, Tschakovsky ME. Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans. J Appl Physiol 2004; 97: 499-508.
34. Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, Crouse JR, et al. Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk 2001; 8: 319-28.
35. Joannides R, Bakkali E, Richard V, Benoist A, Moore N, Thuillez C. Evaluation of the determinants of flow-mediated radial artery vasodilatation in humans. Clin Exp Hypertens 1997; 19: 813-26.
36. De Groot PC, Poelkens F, Kooijman M, Hopman MT. Preserved flow-mediated dilation in the inactive legs of spinal cord-injured individuals. Am J Physiol Heart Circ Physiol 2004; 287: H374-80.
37. Leeson P, Thorne S, Donaed A, Mullen M, Clarkson P, Deanfield J. Non-invasive measurement of endothelial function: effect on brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997; 78: 22-7.
38. Otto ME, Svatikova A, Barretto RB, Santos S, Hoffmann M, Khandheria B, et al. Early morning attenuation of endothelial function in healthy humans. Circulation 2004; 109: 2507-10.
39. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998; 97: 1234-8.
40. Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998; 98: 1158-63.
41. Soga J, Nishioka K, Nakamura S, Umemura T, Jitsuiki D, Hidaka T, et al. Measurement of flow-mediated vasodilation of the brachial artery: a comparison of measurements in the seated and supine positions. Circ J 2007; 71: 736-40.
42. Wendelhag I, Fagerberg B, Wikstrand J. Adding ischaemic hand exercise during occlusion of the brachial artery increases the flow-mediated vasodilation in ultrasound studies of endothelial function. Clin Physiol 1999; 19: 279-83.
43. Lieberman EH, Gerhard MD, Uehata A, Selwyn AP, Ganz P, Yeung AC, et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 1996; 78: 1210-4.
44. Gonzáez AS, Kostine A, Góez-Flores JR, Máquez MF, Hermosillo AG, París JV, et al. Non-invasive assessment of endothelial function. Intra and inter-observer variability. Arch Cardiol Mex 2006; 76: 397-400.
45. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ, et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008; 51: 1959-64.
46. Hijmering ML, Stroes ES, Pasterkamp G, Sierevogel M, Banga JD, Rabelink TJ. Variability of flow mediated dilation: consequences for clinical application. Atherosclerosis 2001; 157: 369-73.
47. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108: 2093-8.
48. Patti G, Pasceri V, Melfi R, Goffredo C, Chello M, D'Ambrosio A, et al. Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation. Circulation 2005; 111: 70-5.
49. Sorensen KE, Celemajer DS, Spieglhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995; 74: 247-53.
50. Moens AL, Goovaerts I, Claeys MJ, Vrints CJ. Flow-mediated vasodilation: a diagnostic instrument, or an experimental tool? Chest 2005; 127: 2254-63.
51. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149-55.
52. Allen JD, Wilson JB, Tulley RT, Lefevre M, Welsch MA. Influence of age and normal plasma fibrinogen levels on flow-mediated dilation in healthy adults. Am J Cardiol 2000; 86: 703-5.
53. Berry KL, Skyrme-Jones RA, Meredith IT. Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation. Clin Sci (Lond) 2000; 99: 261-7.
54. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, et al. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 2001; 38: 1083-8.
55. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82: 1535-9.
56. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JFJ, et al. Clinical correlates and heritability of flowmediated dilation in the community: the Framingham Heart Study. Circulation 2004; 109: 613-9.
57. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24: 471-6.
58. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993; 90: 7915-22.
59. Gokce N, Holbrook M, Duffy SJ, Demissie S, Cupples LA, Biegelsen E, et al. Effects of race and hypertension on flowmediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension 2001; 38: 1349-54.
60. Fathi R, Haluska B, Isbel N, Short L, Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004; 43: 616-23.
61. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115: 2390-7.
62. Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 2009; 134: 52-8.
63. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502-9.
64. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003; 42: 1037-43.
65. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 2002; 105: 1567-72.
66. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000-6.
67. Papaioannou GI, Seip RL, Grey NJ, Katten D, Taylor A, Inzucchi SE, et al. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). Am J Cardiol 2004; 94: 294-9.
68. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
69. Juonala M, Viikari JS, Alfthan G, Marniemi J, Kahonen M, Taittonen L, et al. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study. Circulation 2007; 116: 1367-73.
70. Pretnar-Oblak J, Sabovic M, Pogacnik T, Sebestjen M, Zaletel M. Flow-mediated dilatation and intima-media thickness in patients with lacunar infarctions. Acta Neurol Scand 2006; 113: 273-7.
71. Kim JS, Lee HS, Park HY, Kim SS, Kang HG, Kim NH, et al. Endothelial function in lacunar infarction: a comparison of lacunar infarction, cerebral atherosclerosis and control group. Cerebrovasc Dis 2009; 28: 166-70.
72. Chen PL, Wang PY, Sheu WH, Chen YT, Ho YP, Hu HH, et al. Changes of brachial flow-mediated vasodilation in different ischemic stroke subtypes. Neurology 2006; 67: 1056-8.
73. Castellanos M, Castillo J, García MM, Leira R, Serena J, Chamorro A, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002; 33: 982-7.
74. Pretnar-Oblak J, Zaletel M, Zvan B, Sabovic M, Pogacnik T. Cerebrovascular reactivity lo L-arginine in patients with lacunar infarctions. Cerebrovasc Dis 2006; 21: 180-6.
75. Shutov AA, Baidina TV, Agafonov AV, Siutkina OV, Gaidash GV. Endothelial dysfunction in patients with ischemic stroke. Zh Nevrol Psilhiatr Im S S Korsakova 2005; 14: 42-5.
76. Chlumsky I, Charvát J. Endothelial dysfunction, distensibility and intima-media thickness and aetiology of stroke. J Int Med Res 2005; 33: 555-61.
77. Freestone B, Chong AY, Nuttall S, Lip GY. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels. Thromb Res 2008; 122: 85-90.
78. Stenborg A, Kalimo H, Viitanen M, Terent A, Lind L. Impaired endothelial function of forearm resistance arteries in CADASIL patients. Stroke 2007; 38: 2692-7.
79. Santos-García D, Blanco M, Serena J, Arias S, Millán M, Rodríguez-Yáñez M, et al. Brachial arterial flow mediated dilation in acute ischemic stroke. Eur J Neurol 2009; 16: 684-90.
80. Santos-García D, Blanco M, Serena J, Rodrgíuez-Yáñez M, Leira R, Castillo J. Impaired brachial flow mediated dilation is predictor for new-onset vascular event after stroke. Cerebrovasc Dis 2011; 32: 155-63.
81. Enderle MD, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering HU, et al. Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease. Heart 1998; 80: 349-54.
82. Schroeder S, Enderle MD, Ossen R, Meisner C, Baumbach A, Pfohl M, et al. Noninvasive determination of endotheliummediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. Am Heart J 1999; 138: 731-9.
83. Pretnar-Oblak J, Sabovic M, Zaletel M. Associations between systemic and cerebral endothelial impairment determined by cerebrovascular reactivity to L-arginine. Endothelium 2007; 14: 73-80.
84. Roquer J, Segura T, Serena J, Castillo J. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis 2009; 27 (Suppl 1): S25-37.
85. Pretnar-Oblak J, Sabovic M, Vidmar G, Zaletel M. Evaluation of L-arginine reactivity in comparison with flow-mediated dilatation and intima-media thickness. Ultrasound Med Biol 2007; 33: 1546-51.
86. Pías-Peleteiro JM, Arias-Rivas S, Rodríguez-Yáñez M, Blanco M. Influencia de la disfunción endotelial en la gravedad de la hemorragia intracerebral no traumática. Rev Neurol 2010; 50: 761.
87. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, et al. Endothelial function and peripheral vasomotion in the brachial artery in neurally mediated syncope. Clin Cardiol 2000; 23: 820-4.
88. Galetta F, Franzoni F, Plantinga Y, Ghiadoni L, Merico G, Tocchini L, et al. Endothelial function in young subjects with vaso-vagal syncope. Biomed Pharmacother 2006; 60: 448-52.
89. Silva FA, Rueda-Clausen CF, Silva SY, Zarruk JG, Guzmán JC, Morillo CA, et al. Endothelial function in patients with migraine during the interictal period. Headache 2007; 47: 45-51.
90. Perko D, Pretnar-Oblak J, Sabovic M, Zvan B, Zaletel M. Endothelium-dependent vasodilatation in migraine patients. Cephalalgia 2011; 31: 654-60.
91. Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007; 68: 1563-70.
92. Dede DS, Yavuz B, Yavuz BB, Cankurtaran M, Halil M, Ulger Z, et al. Assessment of endothelial function in Alzheimer's disease: is Alzheimer's disease a vascular disease? J Am Geriatr Soc 2007; 55: 1613-7.